GCC Diabetes Care Devices Market Size, Growth Opportunities & Industry Forecast Report, 2020-2027
GCC Diabetes Care Devices Market & Industry Trends Analysis Report Segmentation By Product Type (Blood Glucose Monitoring Device and Insulin Delivery Device), By End User (Homecare Setting, Hospitals and Others (Clinics, Ambulatory Surgical Centers) and By Country – Opportunities & Forecast, 2020-2027
According to GMI Research’s latest report, the GCC Diabetes Care Devices market was valued at USD XX Million in 2019 and is projected to reach USD XX Million by 2027, growing at a CAGR of 5.3% during 2020-2027.
Diabetes care devices are used to monitor the glucose level in the diabetic patient’s body and facilitate the delivery of insulin into the patient’s body. There are two types of diabetes care devices, including the blood glucose monitoring device and the insulin delivery device. The regular monitoring of diabetes improves outcomes and helps in adjusting treatment in real-time. These devices are often used in hospitals, clinics, and other surgical centers.
To gain an edge over the competition by knowing the market dynamics and current trends of “GCC Diabetes Care Devices Market,” request for Sample Report here
The key factors propelling the growth of the GCC Diabetes Care Devices Market include the growing prevalence of diabetes & obesity, favourable investment initiatives by the government of key economies such as U.A.E and Saudi Arabia pertaining to the development of healthcare sector as well as rising technological advancements. According to the International Diabetes Federation (IDF), the prevalence rate of the diabetes disease amounted to 23.9% in Saudi Arabia, 23.1% in Kuwait, and 19.8% in Qatar. Obesity is drastically increasing across the region, with 60% of the patients are adults and 40% are below the age of 18.
The rising investment in the healthcare sector will have a positive impact on the growing demand for the GCC Diabetes Care Devices Market over the coming years. The diabetes care device manufacturers are mainly focusing on technological development in the product to deliver more accurate results. The continuous product innovation will attract a large number of consumers to opt for advanced devices across the GCC countries. In addition to this, rapid urbanization and high disposable income of the middle-class families is encouraging the customers to adopt for diabetes care devices for regular self-monitoring and tracking of diabetes. On the other hand, the growing consumer awareness regarding the side effects associated with some of the diabetes care devices will hamper the growth of the market during the forecast period.
Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report
The blood glucose monitoring devices are anticipated to lead the market during the forecast period owing to the increased demand for technologically advanced diabetes care devices. The glucose monitoring devices provide accurate measurement of the glucose level and gives a warning if the glucose level goes too low or too high. The insulin delivery devices segment is expected to grow at a higher CAGR during the forecast period due to the growing adoption of these devices among the healthcare professionals and patients driven by its remarkable advantages such as high stability and technological advanced properties.
The home care settings segment is expected to grow at a higher CAGR during the forecast period due to its user-friendly feature at an affordable price range. The end-users have significantly shifted towards the usage of diabetes care devices at home rather than going to clinics or healthcare centers for regular health check-up. Moreover, the continuous technological advancement in these devices, followed by the increasing research and development activities to make the devices more user-friendly will further drive the demand of the market over the coming years.
Saudi Arabia region is anticipated to lead the GCC diabetes care devices market in 2019 owing to the increasing government and private funding towards healthcare infrastructure in GCC countries. The rising aging population and the growing consumer awareness regarding the benefits offered by these devices will encourage the consumers towards the usage of diabetes care devices during the forecast period. The rapid advancement in technologies, along with the numerous initiatives taken by the government to spread awareness, will further propel the demand of these devices in the region.
In case, any of your pain points areas are not covered in the current scope of this report, Request for Customization here
Key Market Developments:
-
- In 2019, Medtronic launched Envision Pro Continuous Glucose Monitoring System to empower healthcare professionals and patients with type 1 or type 2 diabetes to get accurate glucose levels and trend over time which leads to the creation of more favourable diabetes therapy plans.
- In 2018, Medtronic PLC received U.S. Food and Drug Administration (FDA) approval for its Guardian Connect continuous glucose monitoring (CGM) system for diabetic patients within an age range of 14 to 75 years.
- In 2018, Abbott announced that its FreeStyle Libre System, one of the company’s revolutionary glucose monitoring system, will now be available to the Medicare patients.
The GCC Diabetes Care Devices market has been segmented on the basis of product type, end-user, and countries. Based on the product type, the market is segmented into blood glucose monitoring device and insulin delivery device. Based on the end-user, the market is segmented into homecare settings, hospitals, and others.
For detailed scope of the “GCC Diabetes Care Device Market” report request a Sample Copy of the report
Key questions answered in this research report:
-
- At what pace is the Diabetes Care Devices market growing in GCC? What will be the growth trend in the future?
- What are the key drivers and restraints in the GCC diabetes care devices market? What will be the impact of drivers and restraints in the coming years?
- What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the GCC diabetes care devices market?
- What are the various end-user areas and how they are poised to grow?
Report Coverage |
Details |
Market Base Year |
2019 |
Market Forecast Period |
2020-2027 |
Market Revenues Currency |
USD Million |
Base Year & Forecast Units |
Value (USD Million) |
Market Segment | By Product Type, By End User, By Country |
Regional Coverage | GCC |
Companies Profiled | Profiles of Top 10 Major Companies Operating in “GCC Diabetes Care Devices market” |
25% Free Customization Available | We will customize this report up to 25% as a free customization to address our client’s specific requirements |
Market Segmentations:
GCC Diabetes Care Devices market by Product Type
-
- Blood Glucose Monitoring Device
- Insulin Delivery Device
GCC Diabetes Care Devices market by End-User
-
- Hospitals
- Homecare Setting
- Others
GCC Diabetes Care Devices Market by Countries
-
- UAE Diabetes Care Devices Market All-Up (Option 1: Free 25% Customization)
- Saudi Arabia Diabetes Care Devices Market All-Up (Option 2: Free 25% Customization)
- Oman Diabetes Care Devices Market All-Up (Option 3: Free 25% Customization)
- Qatar Diabetes Care Devices Market All-Up (Option 4: Free 25% Customization)
- Kuwait Diabetes Care Devices Market All-Up (Option 5: Free 25% Customization)
- Bahrain Diabetes Care Devices Market All-Up (Option 6: Free 25% Customization)
Frequently Asked Question About This Report
GCC Diabetes Care Devices Market – Published Report [UP320A-00-0420]
Blood Glucose Monitoring Device segment hold the highest revenue share in the GCC Diabetes Care Devices market due to the growth in the adoption rate of such devices among the diabetic population and rising awareness related to the monitoring of blood glucose levels at home is leading to increase in the demand for such products in the market.
GCC Diabetes Care Devices Market has been segmented on the basis of end-user into Homecare settings, Hospitals and Others.
Major companies include Abbott Laboratories, Becton Dickinson and Company, Ascecia, Medtronic PLC, Roche Holding AG, Dexcom Inc., LifeScan IP Holdings, LLC., Terumo Corporation, Novo Norsdisk and Sanofi.
GCC diabetes care devices market is expected to grow at a CAGR of 5.3% during the forecast period.
- Published Date: Oct - 2020
- Report Format: Excel/PPT
- Report Code: UP320A-00-0420
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
GCC Diabetes Care Devices Market Size, Growth Opportunities & Industry Forecast Report, 2020-2027
$ 6,500.00 – $ 8,499.00